Table 1.
Variable | n | post-NAC GR expression | P | post-NAC Sgk1 expression | P | post-NAC NDRG1 expression | P | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
High | Low | High | Low | High | Low | ||||||
Age | ≧65y.o | 62 | 32 | 30 | 35 | 27 | 22 | 40 | |||
< 65y.o | 36 | 20 | 16 | p = 0.706 | 18 | 18 | p = 0.537 | 16 | 20 | p = 0.380 | |
Gender | Male | 83 | 43 | 40 | 48 | 35 | 32 | 41 | |||
Female | 15 | 9 | 6 | p = 0.559 | 5 | 10 | p = 0.080 | 6 | 9 | p = 0.915 | |
pTa | pT1a~pT1b | 28 | 12 | 16 | 9 | 19 | 1 | 27 | |||
pT2~pT4b | 70 | 40 | 30 | p = 0.201 | 44 | 26 | p = 0.006* | 37 | 33 | p < 0.001* | |
pNa | pN0 | 29 | 14 | 15 | 7 | 22 | 9 | 20 | |||
pN1~N3 | 69 | 38 | 31 | p = 0.539 | 46 | 23 | p < 0.001* | 29 | 40 | p = 0.308 | |
cMa | cM0 | 94 | 50 | 44 | 49 | 45 | 36 | 58 | |||
cM1 | 4 | 2 | 2 | p = 0.900 | 4 | 0 | p = 0.060 | 2 | 2 | p = 0.638 | |
pStagea | pStageI,II | 40 | 20 | 20 | 11 | 29 | 9 | 31 | |||
pStageIII,IV | 58 | 32 | 26 | p = 0.614 | 42 | 16 | p < 0.001* | 29 | 29 | p = 0.006* | |
Tumor differentiationa | well,moderate | 84 | 47 | 37 | 44 | 40 | 33 | 51 | |||
poor | 10 | 4 | 6 | p = 0.339 | 8 | 2 | p = 0.097 | 5 | 5 | p = 0.517 | |
Unclassifiable | 4 | 1 | 3 | 1 | 3 | 0 | 4 | ||||
Lymphatic invasion | Absence | 29 | 14 | 15 | 9 | 20 | 9 | 20 | |||
Presence | 69 | 38 | 31 | p = 0.538 | 44 | 25 | p = 0.003* | 29 | 40 | p = 0.308 | |
Vessel invasion | Absence | 18 | 5 | 13 | 6 | 12 | 3 | 15 | |||
Presence | 80 | 47 | 33 | p = 0.016* | 47 | 33 | p = 0.051 | 35 | 45 | p = 0.033* | |
RECIST gradeb | CR/PR | 28 | 12 | 16 | 10 | 18 | 8 | 20 | |||
SD/PD | 57 | 34 | 23 | p = 0.144 | 38 | 19 | p = 0.007* | 28 | 29 | p = 0.072 | |
Indeterminate | 13 | 6 | 7 | 5 | 8 | 2 | 11 | ||||
Histopathological tumor regression gradec | Grade0~1a | 63 | 37 | 26 | 39 | 24 | 27 | 36 | |||
Grade1b~ 2 | 35 | 15 | 20 | p = 0.131 | 14 | 21 | p = 0.037* | 11 | 24 | p = 0.267 | |
Total | 98 | 52 | 46 | 53 | 45 | 38 | 60 |
* Statistical significance
a Tumor-node-metastasis (TNM) classification based on the 8th edition of the TNM classification of malignant tumors
b New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1)
c Histopathological features based on the Japanese Classification of Esophageal Cancer, 11th edition (Japan Esophageal Society 2015)